SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology EquipmentCell Culture

PUBLISHER: Persistence Market Research | PRODUCT CODE: 2039848

Cover Image

PUBLISHER: Persistence Market Research | PRODUCT CODE: 2039848

Cell Tissue Culture Supplies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

PUBLISHED:
PAGES: 195 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
PDF & Excel (Multi User License)
USD 7295
PDF & Excel (Corporate User License)
USD 8495

Add to Cart

Description

Table of Contents

Persistence Market Research has recently released a comprehensive report on the global Cell Tissue Culture Supplies Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Cell Tissue Culture Supplies Market Size (2025E): US$ 16.8 Bn
  • Projected Market Value (2032F): US$ 35.1 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 11.1%

Cell Tissue Culture Supplies Market - Report Scope:

The cell tissue culture supplies market comprises a broad range of products and consumables used in the cultivation and maintenance of cells and tissues for research, biopharmaceutical production, diagnostics, and regenerative medicine applications. These supplies include media, sera, reagents, vessels, and accessories essential for laboratory and industrial cell culture processes. The increasing demand for biopharmaceuticals, advancements in stem cell research, and growing investments in biotechnology and life sciences are significantly contributing to the expansion of the global cell tissue culture supplies market.

Market Growth Drivers:

The global cell tissue culture supplies market is witnessing substantial growth due to the increasing prevalence of chronic diseases and the rising demand for biologics and cell-based therapies. Growing investments in pharmaceutical and biotechnology research activities, particularly in regenerative medicine and stem cell technologies, are driving the adoption of advanced cell culture products. In addition, the expanding application of cell culture techniques in cancer research, vaccine development, and drug screening is further supporting market growth. Technological advancements in serum-free and chemically defined media are also improving efficiency and reproducibility in laboratory procedures, thereby fueling market expansion.

Market Restraints:

Despite its strong growth potential, the cell tissue culture supplies market faces several challenges. High costs associated with advanced cell culture media, reagents, and laboratory infrastructure can limit adoption, particularly among small research organizations and academic institutions. Additionally, contamination risks during cell culture procedures and stringent regulatory requirements for biopharmaceutical manufacturing may hinder market growth. Ethical concerns associated with the use of animal-derived sera and technical complexities involved in maintaining cell cultures can also restrict widespread adoption.

Market Opportunities:

The cell tissue culture supplies market presents significant opportunities driven by increasing advancements in personalized medicine, regenerative therapies, and tissue engineering. Rising demand for 3D cell culture technologies and organoid research is expected to create new avenues for product innovation and market expansion. Emerging economies in Asia-Pacific and Latin America are offering lucrative growth prospects due to expanding healthcare infrastructure and increasing investments in biotechnology research. Furthermore, strategic collaborations between research institutes, pharmaceutical companies, and biotechnology firms are anticipated to accelerate the development of innovative cell culture solutions.

Key Questions Answered in the Report:

  • What are the primary factors driving the global cell tissue culture supplies market's growth?
  • Which regions and market segments are experiencing the highest demand for cell tissue culture supplies?
  • How are technological advancements in cell culture products influencing market dynamics?
  • Who are the key players in the cell tissue culture supplies market, and what strategies are they adopting to stay competitive?
  • What are the emerging trends and future projections for the global cell tissue culture supplies market?

Competitive Intelligence and Business Strategy:

Leading companies in the global cell tissue culture supplies market are focusing on product innovation, strategic partnerships, acquisitions, and expansion of manufacturing capabilities to strengthen their market position. These companies are investing heavily in research and development activities to introduce advanced media formulations, contamination-free reagents, and automated cell culture systems. Collaborations with academic institutions and biotechnology companies are helping manufacturers enhance their product portfolios and expand their global presence. Additionally, the growing emphasis on serum-free and chemically defined media is enabling companies to address regulatory concerns and improve product reliability.

Companies Covered in This Report:

  • Thermo Fisher Scientific, Inc.
  • BD
  • Merck GmbH
  • ATCC
  • STEMCELL Technologies
  • REPROCELL Inc.
  • Corning Incorporated
  • Fisher Biotec
  • Takara Bio Inc
  • Miltenyi Biotec
  • Plant Cell Technology Inc.
  • Life Technologies (India) Pvt Ltd.
  • SABEU GmbH & Co. KG
  • Globe Scientific Inc.
  • Biogenuix
  • ESAW Microscopes and Labware
  • PhytoTech Labs, Inc.
  • HiMedia Laboratories
  • Nuaire
  • Central Drug House
  • Stellar Scientific
  • Alpha Laboratories
  • Genbiotek Biosistem Laboratuvar Malzemeleri Sanayi ve Ticaret Limited
  • CEDARLANE

Market Segmentation

By Product

  • Media
  • Serum Containing Media
  • Serum-Free Media
  • Protein Expression Media
  • Stem Cell Media
  • Hybridoma Media
  • Primary Cell Media
  • Insect Cell Media
  • Immunology Media
  • CHO Cell Culture Media
  • Protein-Free Media
  • Chemically Defined Media
  • Sera
  • Fetal Bovine Sera (FBS)
  • Adult Bovine Sera (ABS)
  • Other Animal Sera
  • Reagents
  • Growth Factors
  • Supplements
  • Buffers & Chemicals
  • Cell Dissociation Reagents
  • Cryoprotective Agents
  • Others
  • Vessels
  • Roller/Roux Bottles
  • Cell Stacks
  • Multiwell Plates
  • Flasks
  • Petri Dishes
  • Accessories

By Application

  • Biopharmaceutical Production
  • Clinical Diagnostics
  • Drug Screening & Development
  • Tissue Engineering & Regenerative Medicine
  • Stem Cell Technologies
  • Cancer Research

By End-User

  • Pharma and Biopharmaceutical Companies
  • Hospitals & Diagnostic Laboratories
  • Academic & Research Institutes
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa
Show more
Product Code: PMRREP3221

Table of Contents

1. Executive Summary

  • 1.1. Global Cell Tissue Culture Supplies Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Global Cell Tissue Culture Supplies Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 4.3. Global Cell Tissue Culture Supplies Market Outlook: Product
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2024
    • 4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
      • 4.3.3.1. Media
        • 4.3.3.1.1. Serum Containing Media
        • 4.3.3.1.2. Serum- Free Media
        • 4.3.3.1.2.1. Protein Expression Media
        • 4.3.3.1.2.2. Stem Cell Media
        • 4.3.3.1.2.3. Hybridoma Media
        • 4.3.3.1.2.4. Primary Cell Media
        • 4.3.3.1.2.5. Insect Cell Media
        • 4.3.3.1.2.6. Immunology Media
        • 4.3.3.1.2.7. CHO Cell Culture Media
        • 4.3.3.1.3. Protein-Free Media
        • 4.3.3.1.4. Chemically Defined Media
      • 4.3.3.2. Sera
        • 4.3.3.2.1. Fetal Bovine Sera (FBS)
        • 4.3.3.2.2. Adult Bovine Sera (ABS)
        • 4.3.3.2.3. Other Animal Sera
      • 4.3.3.3. Reagents
        • 4.3.3.3.1. Growth Factors
        • 4.3.3.3.2. Supplements
        • 4.3.3.3.3. Buffers & Chemicals
        • 4.3.3.3.4. Cell Dissociation Reagents
        • 4.3.3.3.5. Cryoprotective Agents
        • 4.3.3.3.6. Others
      • 4.3.3.4. Vessels
        • 4.3.3.4.1. Roller/Roux Bottles
        • 4.3.3.4.2. Cell Stacks
        • 4.3.3.4.3. Multiwell Plates
        • 4.3.3.4.4. Flasks
        • 4.3.3.4.5. Petri Dishes
      • 4.3.3.5. Accessories
    • 4.3.4. Market Attractiveness Analysis: Product
  • 4.4. Global Cell Tissue Culture Supplies Market Outlook: Application
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
    • 4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      • 4.4.3.1. Biopharmaceutical Production
      • 4.4.3.2. Clinical Diagnostics
      • 4.4.3.3. Drug Screening & Development
      • 4.4.3.4. Tissue Engineering & Regenerative Medicine
      • 4.4.3.5. Stem Cell Technologies
      • 4.4.3.6. Cancer Research
    • 4.4.4. Market Attractiveness Analysis: Application
  • 4.5. Global Cell Tissue Culture Supplies Market Outlook: End User
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2024
    • 4.5.3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
      • 4.5.3.1. Pharma and Biopharmaceutical Companies
      • 4.5.3.2. Hospitals & Diagnostic Laboratories
      • 4.5.3.3. Academic and Research Institutes
      • 4.5.3.4. Others
    • 4.5.4. Market Attractiveness Analysis: End User

5. Global Cell Tissue Culture Supplies Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
  • 5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Cell Tissue Culture Supplies Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Product
    • 6.2.3. By Application
    • 6.2.4. By End User
  • 6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 6.4.1. Media
      • 6.4.1.1. Serum Containing Media
      • 6.4.1.2. Serum- Free Media
        • 6.4.1.2.1. Protein Expression Media
        • 6.4.1.2.2. Stem Cell Media
        • 6.4.1.2.3. Hybridoma Media
        • 6.4.1.2.4. Primary Cell Media
        • 6.4.1.2.5. Insect Cell Media
        • 6.4.1.2.6. Immunology Media
        • 6.4.1.2.7. CHO Cell Culture Media
      • 6.4.1.3. Protein-Free Media
      • 6.4.1.4. Chemically Defined Media
    • 6.4.2. Sera
      • 6.4.2.1. Fetal Bovine Sera (FBS)
      • 6.4.2.2. Adult Bovine Sera (ABS)
      • 6.4.2.3. Other Animal Sera
    • 6.4.3. Reagents
      • 6.4.3.1. Growth Factors
      • 6.4.3.2. Supplements
      • 6.4.3.3. Buffers & Chemicals
      • 6.4.3.4. Cell Dissociation Reagents
      • 6.4.3.5. Cryoprotective Agents
      • 6.4.3.6. Others
    • 6.4.4. Vessels
      • 6.4.4.1. Roller/Roux Bottles
      • 6.4.4.2. Cell Stacks
      • 6.4.4.3. Multiwell Plates
      • 6.4.4.4. Flasks
      • 6.4.4.5. Petri Dishes
    • 6.4.5. Accessories
  • 6.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 6.5.1. Biopharmaceutical Production
    • 6.5.2. Clinical Diagnostics
    • 6.5.3. Drug Screening & Development
    • 6.5.4. Tissue Engineering & Regenerative Medicine
    • 6.5.5. Stem Cell Technologies
    • 6.5.6. Cancer Research
  • 6.6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 6.6.1. Pharma and Biopharmaceutical Companies
    • 6.6.2. Hospitals & Diagnostic Laboratories
    • 6.6.3. Academic and Research Institutes
    • 6.6.4. Others
  • 6.7. Market Attractiveness Analysis

7. Europe Cell Tissue Culture Supplies Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By End User
  • 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. Media
      • 7.4.1.1. Serum Containing Media
      • 7.4.1.2. Serum- Free Media
        • 7.4.1.2.1. Protein Expression Media
        • 7.4.1.2.2. Stem Cell Media
        • 7.4.1.2.3. Hybridoma Media
        • 7.4.1.2.4. Primary Cell Media
        • 7.4.1.2.5. Insect Cell Media
        • 7.4.1.2.6. Immunology Media
        • 7.4.1.2.7. CHO Cell Culture Media
      • 7.4.1.3. Protein-Free Media
      • 7.4.1.4. Chemically Defined Media
    • 7.4.2. Sera
      • 7.4.2.1. Fetal Bovine Sera (FBS)
      • 7.4.2.2. Adult Bovine Sera (ABS)
      • 7.4.2.3. Other Animal Sera
    • 7.4.3. Reagents
      • 7.4.3.1. Growth Factors
      • 7.4.3.2. Supplements
      • 7.4.3.3. Buffers & Chemicals
      • 7.4.3.4. Cell Dissociation Reagents
      • 7.4.3.5. Cryoprotective Agents
      • 7.4.3.6. Others
    • 7.4.4. Vessels
      • 7.4.4.1. Roller/Roux Bottles
      • 7.4.4.2. Cell Stacks
      • 7.4.4.3. Multiwell Plates
      • 7.4.4.4. Flasks
      • 7.4.4.5. Petri Dishes
    • 7.4.5. Accessories
  • 7.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 7.5.1. Biopharmaceutical Production
    • 7.5.2. Clinical Diagnostics
    • 7.5.3. Drug Screening & Development
    • 7.5.4. Tissue Engineering & Regenerative Medicine
    • 7.5.5. Stem Cell Technologies
    • 7.5.6. Cancer Research
  • 7.6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 7.6.1. Pharma and Biopharmaceutical Companies
    • 7.6.2. Hospitals & Diagnostic Laboratories
    • 7.6.3. Academic and Research Institutes
    • 7.6.4. Others
  • 7.7. Market Attractiveness Analysis

8. East Asia Cell Tissue Culture Supplies Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By End User
  • 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. Media
      • 8.4.1.1. Serum Containing Media
      • 8.4.1.2. Serum- Free Media
        • 8.4.1.2.1. Protein Expression Media
        • 8.4.1.2.2. Stem Cell Media
        • 8.4.1.2.3. Hybridoma Media
        • 8.4.1.2.4. Primary Cell Media
        • 8.4.1.2.5. Insect Cell Media
        • 8.4.1.2.6. Immunology Media
        • 8.4.1.2.7. CHO Cell Culture Media
      • 8.4.1.3. Protein-Free Media
      • 8.4.1.4. Chemically Defined Media
    • 8.4.2. Sera
      • 8.4.2.1. Fetal Bovine Sera (FBS)
      • 8.4.2.2. Adult Bovine Sera (ABS)
      • 8.4.2.3. Other Animal Sera
    • 8.4.3. Reagents
      • 8.4.3.1. Growth Factors
      • 8.4.3.2. Supplements
      • 8.4.3.3. Buffers & Chemicals
      • 8.4.3.4. Cell Dissociation Reagents
      • 8.4.3.5. Cryoprotective Agents
      • 8.4.3.6. Others
    • 8.4.4. Vessels
      • 8.4.4.1. Roller/Roux Bottles
      • 8.4.4.2. Cell Stacks
      • 8.4.4.3. Multiwell Plates
      • 8.4.4.4. Flasks
      • 8.4.4.5. Petri Dishes
    • 8.4.5. Accessories
  • 8.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 8.5.1. Biopharmaceutical Production
    • 8.5.2. Clinical Diagnostics
    • 8.5.3. Drug Screening & Development
    • 8.5.4. Tissue Engineering & Regenerative Medicine
    • 8.5.5. Stem Cell Technologies
    • 8.5.6. Cancer Research
  • 8.6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 8.6.1. Pharma and Biopharmaceutical Companies
    • 8.6.2. Hospitals & Diagnostic Laboratories
    • 8.6.3. Academic and Research Institutes
    • 8.6.4. Others
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Cell Tissue Culture Supplies Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By End User
  • 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. Media
      • 9.4.1.1. Serum Containing Media
      • 9.4.1.2. Serum- Free Media
        • 9.4.1.2.1. Protein Expression Media
        • 9.4.1.2.2. Stem Cell Media
        • 9.4.1.2.3. Hybridoma Media
        • 9.4.1.2.4. Primary Cell Media
        • 9.4.1.2.5. Insect Cell Media
        • 9.4.1.2.6. Immunology Media
        • 9.4.1.2.7. CHO Cell Culture Media
      • 9.4.1.3. Protein-Free Media
      • 9.4.1.4. Chemically Defined Media
    • 9.4.2. Sera
      • 9.4.2.1. Fetal Bovine Sera (FBS)
      • 9.4.2.2. Adult Bovine Sera (ABS)
      • 9.4.2.3. Other Animal Sera
    • 9.4.3. Reagents
      • 9.4.3.1. Growth Factors
      • 9.4.3.2. Supplements
      • 9.4.3.3. Buffers & Chemicals
      • 9.4.3.4. Cell Dissociation Reagents
      • 9.4.3.5. Cryoprotective Agents
      • 9.4.3.6. Others
    • 9.4.4. Vessels
      • 9.4.4.1. Roller/Roux Bottles
      • 9.4.4.2. Cell Stacks
      • 9.4.4.3. Multiwell Plates
      • 9.4.4.4. Flasks
      • 9.4.4.5. Petri Dishes
    • 9.4.5. Accessories
  • 9.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 9.5.1. Biopharmaceutical Production
    • 9.5.2. Clinical Diagnostics
    • 9.5.3. Drug Screening & Development
    • 9.5.4. Tissue Engineering & Regenerative Medicine
    • 9.5.5. Stem Cell Technologies
    • 9.5.6. Cancer Research
  • 9.6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 9.6.1. Pharma and Biopharmaceutical Companies
    • 9.6.2. Hospitals & Diagnostic Laboratories
    • 9.6.3. Academic and Research Institutes
    • 9.6.4. Others
  • 9.7. Market Attractiveness Analysis

10. Latin America Cell Tissue Culture Supplies Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By End User
  • 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. Media
      • 10.4.1.1. Serum Containing Media
      • 10.4.1.2. Serum- Free Media
        • 10.4.1.2.1. Protein Expression Media
        • 10.4.1.2.2. Stem Cell Media
        • 10.4.1.2.3. Hybridoma Media
        • 10.4.1.2.4. Primary Cell Media
        • 10.4.1.2.5. Insect Cell Media
        • 10.4.1.2.6. Immunology Media
        • 10.4.1.2.7. CHO Cell Culture Media
      • 10.4.1.3. Protein-Free Media
      • 10.4.1.4. Chemically Defined Media
    • 10.4.2. Sera
      • 10.4.2.1. Fetal Bovine Sera (FBS)
      • 10.4.2.2. Adult Bovine Sera (ABS)
      • 10.4.2.3. Other Animal Sera
    • 10.4.3. Reagents
      • 10.4.3.1. Growth Factors
      • 10.4.3.2. Supplements
      • 10.4.3.3. Buffers & Chemicals
      • 10.4.3.4. Cell Dissociation Reagents
      • 10.4.3.5. Cryoprotective Agents
      • 10.4.3.6. Others
    • 10.4.4. Vessels
      • 10.4.4.1. Roller/Roux Bottles
      • 10.4.4.2. Cell Stacks
      • 10.4.4.3. Multiwell Plates
      • 10.4.4.4. Flasks
      • 10.4.4.5. Petri Dishes
    • 10.4.5. Accessories
  • 10.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 10.5.1. Biopharmaceutical Production
    • 10.5.2. Clinical Diagnostics
    • 10.5.3. Drug Screening & Development
    • 10.5.4. Tissue Engineering & Regenerative Medicine
    • 10.5.5. Stem Cell Technologies
    • 10.5.6. Cancer Research
  • 10.6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 10.6.1. Pharma and Biopharmaceutical Companies
    • 10.6.2. Hospitals & Diagnostic Laboratories
    • 10.6.3. Academic and Research Institutes
    • 10.6.4. Others
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Cell Tissue Culture Supplies Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By End User
  • 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. Media
      • 11.4.1.1. Serum Containing Media
      • 11.4.1.2. Serum- Free Media
        • 11.4.1.2.1. Protein Expression Media
        • 11.4.1.2.2. Stem Cell Media
        • 11.4.1.2.3. Hybridoma Media
        • 11.4.1.2.4. Primary Cell Media
        • 11.4.1.2.5. Insect Cell Media
        • 11.4.1.2.6. Immunology Media
        • 11.4.1.2.7. CHO Cell Culture Media
      • 11.4.1.3. Protein-Free Media
      • 11.4.1.4. Chemically Defined Media
    • 11.4.2. Sera
      • 11.4.2.1. Fetal Bovine Sera (FBS)
      • 11.4.2.2. Adult Bovine Sera (ABS)
      • 11.4.2.3. Other Animal Sera
    • 11.4.3. Reagents
      • 11.4.3.1. Growth Factors
      • 11.4.3.2. Supplements
      • 11.4.3.3. Buffers & Chemicals
      • 11.4.3.4. Cell Dissociation Reagents
      • 11.4.3.5. Cryoprotective Agents
      • 11.4.3.6. Others
    • 11.4.4. Vessels
      • 11.4.4.1. Roller/Roux Bottles
      • 11.4.4.2. Cell Stacks
      • 11.4.4.3. Multiwell Plates
      • 11.4.4.4. Flasks
      • 11.4.4.5. Petri Dishes
    • 11.4.5. Accessories
  • 11.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 11.5.1. Biopharmaceutical Production
    • 11.5.2. Clinical Diagnostics
    • 11.5.3. Drug Screening & Development
    • 11.5.4. Tissue Engineering & Regenerative Medicine
    • 11.5.5. Stem Cell Technologies
    • 11.5.6. Cancer Research
  • 11.6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 11.6.1. Pharma and Biopharmaceutical Companies
    • 11.6.2. Hospitals & Diagnostic Laboratories
    • 11.6.3. Academic and Research Institutes
    • 11.6.4. Others
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Thermo Fisher Scientific, Inc.
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Product Types
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. BD
    • 12.3.3. Merck GmbH
    • 12.3.4. ATCC
    • 12.3.5. STEMCELL Technologies
    • 12.3.6. REPROCELL Inc.
    • 12.3.7. Corning Incorporated
    • 12.3.8. Fisher Biotec
    • 12.3.9. Takara Bio Inc
    • 12.3.10. Miltenyi Biotec
    • 12.3.11. Plant Cell Technology Inc.
    • 12.3.12. Life Technologies (India) Pvt Ltd.
    • 12.3.13. SABEU GmbH & Co. KG
    • 12.3.14. Globe Scientific Inc.
    • 12.3.15. Biogenuix
    • 12.3.16. ESAW Microscopes and Labware
    • 12.3.17. PhytoTech Labs, Inc.
    • 12.3.18. HiMedia Laboratories
    • 12.3.19. Nuaire
    • 12.3.20. Central Drug House
    • 12.3.21. Stellar Scientific
    • 12.3.22. Alpha Laboratories
    • 12.3.23. Genbiotek Biosistem Laboratuvar Malzemeleri Sanayi ve Ticaret Limited
    • 12.3.24. CEDARLANE

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!